Navigation Links
Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
Date:1/27/2009

NEW YORK, Jan. 27 /PRNewswire/ -- A study by healthcare market research firm Manhattan Research found that only 9% of U.S. physicians oppose commercial support for continuing medical education (CME) funding. The results of this study are relevant to the ongoing discussion in the medical community about the role of commercial funding of CME.

In an effort to better understand the positions of those who actually use continuing medical education, Manhattan Research surveyed physicians on their opinions with regard to their use and the potential bias of industry-funded programs. The Manhattan Research study reports that only 8% of physicians who participated in CME believe that it is biased. In fact, if commercial support is halted, nearly half of the physicians surveyed would decrease their use of CME.

According to the study, almost all physicians utilize CME programs to maintain and grow their medical knowledge and to keep up-to-date on the latest advances in their specialty with the ultimate goal of improving patient care. Pharmaceutical companies are a funding source for CME programs, which has prompted some critics to question their influence over CME course content. In response, the Accreditation Council for Continuing Medical Education (ACCME), the organization that accredits CME Providers, has augmented its standards and guidelines to ensure the independence of commercially supported CME activities. The American Medical Association's Council on Ethical and Judicial Affairs (CEJA) is also expected to issue a new report on commercially-supported CME later this year.

"While there's been debate around the value of industry-supported CME, as our study reveals, it's important to listen to the voice of the majority of physicians," said Mark Bard, Manhattan Research President. "Rather than pulling the plug on a vital source of CME funding, the primary beneficiaries of CME - physicians and patients - would be best served by continued improvements to course availability, offerings, and content through increased collaboration among medical and academic organizations, the pharmaceutical industry, CME providers, and accreditation bodies."

About the Study

Healthcare market research firm Manhattan Research conducted a survey to gauge physician opinion on commercially-funded CME and the proposed ban. The online study was fielded in the third quarter of 2008 among a nationally representative sample of U.S. physicians, including primary care and specialist audiences.

Manhattan Research Products and Services

Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com, email sales@manhattanresearch.com or call 1.888.680.0800.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Manhattan Research
    Maureen Malloy
    212-255-7799
    mmalloy@manhattanresearch.com

    Decision Resources, Inc.
    Elizabeth Marshall
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Manhattan Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
2. The Massage Spot Announces Opening of Manhattan Beach Location; Seeks Investors for Growth of Affordable Luxury Mini Day Spa Concept
3. Eli Manning Leads March for Babies in Manhattan
4. 1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11
5. Manhattan Scientifics Acquires Metallicum, Inc.
6. Stanford researchers find culprit in aging muscles that heal poorly
7. Children of depressed moms do better when dad is involved, SLU researcher finds
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
10. New research shows how chronic stress worsens neurodegenerative disease course
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , ... May 23, 2017 , ... ... and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment ... collagen and elastin in their face, neck, and body through a virtually pain-free, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Drs. Allen Huang and ... in Las Vegas, NV, and the importance of treating it immediately. They ... leading care for peri-implantitis, with or without a referral. As experienced periodontists and ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, an ... a standard feature on its secure clinical communication platform. The platform allows clinicians ... depending on the type and urgency of a situation. , “We know ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Orbita’s Nathan Treloar ... May 23, 2017 in San Francisco. Titled Connected Health and IoT: Technology Innovators ... Event hosted by Parks Associates, a market research and consulting firm specializing in ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... receive treatment using the SPEED System™ Orthodontics, with or without a referral, from ... in El Segundo, CA, who is skilled in providing patients with the ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 2017 Clarius Mobile Health, a digital ... scanners this week at the American Congress of ... San Diego, CA from ... the perfect tool for clinicians to easily confirm ... evaluate pregnancy-related complications like ectopic pregnancy and placenta ...
(Date:5/4/2017)... WAYNE, Pa. , May 4, 2017 /PRNewswire/ ... made from thermoplastics and other highly-engineered materials, is ... Microextrusion tubing has been developed in recent ... neurovascular interventional therapies and surgical applications. More expensive ... used to produce microextrusion tubing due to their ...
(Date:5/3/2017)...  Kalorama Information notes that transplant diagnostics is ... and this is projected to continue to 2021. ... or bone marrow transplants require histocompatibility between the ... this task. This according to a new report ... various PCR-based methodologies, Sanger sequencing and NGS used ...
Breaking Medicine Technology: